Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) research hub

A trial to investigate the effect on overall health and functioning in patients with Lewy body dementia of memantine as an add-on treatment to a cholinesterase inhibitor

The COBALT trial is testing whether adding a drug called memantine to standard dementia medicines helps people with Lewy body dementia or Parkinson's disease dementia. Researchers want to see if this combination improves daily living, memory, and overall well-being for patients and makes everyday life easier for their carers.